The D-dimer assay on the Stratus® CS 200 Acute Care™ Diagnostic Analyzer is an in vitro diagnostic test for the quantitative measurement of cross-linked fibrin degradation products (D-dimer) in human citrated or heparinized plasma. The Stratus CS D-dimer assay is intended for use in conjunction with a non-high clinical pretest probability (PTP) assessment model to exclude pulmonary embolism (PE) disease and as an aid in the diagnosis of venous thromboembolism (VTE) [deep vein thrombosis (DVT) or pulmonary embolism (PE)].
- Rapid turnaround time—in as little as 14 minutes (with on-board centrifugation).
- Single‐use TestPak™ cartridges significantly reduce contamination and open‐stability issues, reducing reagent waste.
- A negative D‐dimer test in conjunction with a low pretest probability score can exclude PE and may reduce unnecessary diagnostic imaging.